SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-022688
Filing Date
2018-04-26
Accepted
2018-04-26 16:16:22
Documents
3
Period of Report
2018-04-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv492072_8k.htm 8-K 18762
2 EXHIBIT 99.1 tv492072_ex99-1.htm EX-99.1 206781
3 GRAPHIC image_001.jpg GRAPHIC 5898
  Complete submission text file 0001144204-18-022688.txt   234992
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 18778758
SIC: 2834 Pharmaceutical Preparations